Home/Filings/4/0001104659-22-095149
4//SEC Filing

Kim Jiny 4

Accession 0001104659-22-095149

CIK 0001175151other

Filed

Aug 25, 8:00 PM ET

Accepted

Aug 26, 4:32 PM ET

Size

5.5 KB

Accession

0001104659-22-095149

Insider Transaction Report

Form 4
Period: 2022-08-25
Kim Jiny
Director
Transactions
  • Purchase

    Common Stock

    2022-08-25$1.91/sh+1,000$1,91070,300 total
Footnotes (2)
  • [F1]The transaction reported on this Form 4 were open market purchases made by the reporting person pursuant to a trading plan adopted by the reporting person that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
  • [F2]Includes (a) 69,300 restricted stock units ("RSUs") granted on April 1, 2022 that will be settled into shares of the Issuer's common stock upon vesting upon a "Change In Control" of the Issuer as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan") and (b) 1,000 shares of owned directly reported by the reporting person and reported on this Form 4.

Issuer

Cytosorbents Corp

CIK 0001175151

Entity typeother

Related Parties

1
  • filerCIK 0001920967

Filing Metadata

Form type
4
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 4:32 PM ET
Size
5.5 KB